Co-expression of vascular endothelial growth factor C (VEGF-C) and c-erbB2 in human breast carcinoma

By Hoar F.J.   Chaudhri S.   Wadley M.S.   Stonelake P.S.  

European Journal of Cancer, Vol. 39, Iss. 12, 2003-08 ,pp. : 1698-1703

Elsevier

Access to resources Recommend Favorite

Inhibiting effect of vascular endothelial growth factor (VEGF) antisense oligodeoxynucleotides on VEGF expression in U937 cells

By He Xiaoyan   Tong Yunjie   Zhang Min   Zou Ping  

The Chinese-German Journal of Clinical Oncology, Vol. 5, Iss. 6, 2006-12 ,pp. : 420-422

Springer Publishing Company

Access to resources Recommend Favorite

Expression of vascular endothelial growth factor (VEGF) and its receptors in human neuroblastoma

By Meister B.   Grunebach   Bautz F.   Brugger W.   Fink F.-M.   Kanz L.   Mohle R.  

European Journal of Cancer, Vol. 35, Iss. 3, 1999-03 ,pp. : 445-449

Elsevier

Access to resources Recommend Favorite

Differences of vascular endothelial growth factor (VEGF) expression between liver and abdominal metastases from colon cancer. Implications for the treatment with VEGF inhibitors

By Cascinu Stefano   Graziano Francesco   Catalano Vincenzo   Staccioli Maria   Barni Sandro   Giordani Paolo   Cristina Rossi Maria   Baldelli Anna   Muretto Pietro   Valenti Andrea   Catalano Giuseppina  

Clinical and Experimental Metastasis, Vol. 18, Iss. 8, 2000-12 ,pp. : 651-655

Springer Publishing Company

Access to resources Recommend Favorite

Targeting Vascular Endothelial Growth Factor (VEGF) for Anti-tumor Therapy, by Anti-VEGF Neutralizing Monoclonal Antibodies or by VEGF Receptor Tyrosine-kinase Inhibitors

By Schlaeppi J-M.  

Cancer and Metastasis Reviews, Vol. 18, Iss. 4, 1999-12 ,pp. : 473-481

Springer Publishing Company

Access to resources Recommend Favorite